Investigations by Type
Notice something we are missing?
Get in Touch Today
5 Alternatives to Zantac
5 Signs You Have Hernia Mesh Complications
Cobalt Toxicity: The Poison in Her Hip Replacement
Investigations by Type
January 6, 2022
By MedTruth Editors
A number of direct purchasers are pushing back, filing an antitrust class-action lawsuit against the e-cigarette giant Juul Labs and its minority stakeholder Altria according to Law360. The direct purchaser plaintiffs allege that Juul conspired with the Altria Group to tighten their hold over the e-cigarette market.
Unlike consumers who purchase e-cigarettes from a store or through an intermediary (indirect purchasers), direct purchasers are the companies and stores that buy directly from the manufacturers themselves.
The current struggle that many direct purchasers face in pursuing the current antitrust action against Juul and Altria is that there was an agreement to terms and conditions that included a forced arbitration clause on the distributor’s website.
Under the forced arbitration clause, California-based U.S. District Judge William H. Orrick has determined that some members of this potential class-action will be unable to sue until they satisfy the arbitration clause of the terms and conditions. However, this forced arbitration will only apply to the distributors who used the site during or after 2021.
If enforced, the direct purchasers would have to take their antitrust case to arbitration before being allowed to go to trial. The current antitrust lawsuit alleges that the 35% purchase of Juul Labs by the Altria Group was part of a conspiracy to push Altria out of the e-cigarette marketplace in a bid for supremacy over e-cigarette prices.
Katharine L. Malone, attorney for the plaintiffs, has argued that the terms and conditions pages have not adequately alerted direct purchasers to the fact that they are being locked into a forced arbitration agreement.
While Malone acknowledges that the page is in its best state, she argues that the decision to force arbitration should not be based on the most recent edition of the terms and conditions, especially since the most recent member joining the class action did so in 2020.
In addition to this class-action from direct purchasers, Juul Labs and Altria also face allegations that they marketed e-cigarettes to children.
JUUL is a non-tobacco, e-cigarette product intended to wean smokers off traditional cigarettes.
JUUL e-cigarettes have been linked to more than 800 cases of lung injury and respiratory illness.
The FDA has issued a warning to consumers about the potential for lung injuries.
E-cigarette users suffering from lung injury can submit adverse event reports and seek counsel.
MedTruth Editors · December 14, 2021
The judge has thrown out 19 plaintiffs suing Juul Labs for injuries and deceitful marketing.
MedTruth Editors · November 5, 2021
The FDA has has authorized the first e-cigarette on the market, and it’s not JUUL.
MedTruth Editors · September 21, 2021
The FDA’s judgment on JUUL is in the final stages of review.
Search the Site
Follow Us Online
Get In Touch Today